Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
8.71
-0.10 (-1.14%)
Jun 27, 2025, 4:00 PM - Market closed
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $475.01 million as of June 27, 2025.
Market Cap
475.01M
Enterprise Value
13.54M
1-Year Change
n/a
Ranking
Category
Stock Price
8.71
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has decreased from $931.70M to $475.01M, a decrease of -49.02%. That is a compound annual growth rate of -58.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 514.28M | -45.75% |
| Dec 31, 2024 | 947.92M | 1.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.60B |
| Johnson & Johnson | 366.93B |
| AbbVie | 329.70B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 275.12B |
| Abbott Laboratories | 232.67B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |